Crescita Therapeutics
(OTC) CRRTF
Crescita Therapeutics Financials at a Glance
Market Cap
$10.05M
Revenue (TTM)
$21.11M
Net Income (TTM)
$91.42K
EPS (TTM)
$-0.00
P/E Ratio
-257.14
Dividend
$0.00
Beta (Volatility)
-0.57 (Low)
Dividend
$0.00
Beta (Volatility)
-0.57 (Low)
Price
$0.54
Volume
4
Open
$0.54
Price
$0.54
Volume
4
Open
$0.54
Previous Close
$0.54
Daily Range
$0.54 - $0.54
52-Week Range
$0.02 - $0.55
Dividend
$0.00
Beta (Volatility)
-0.57 (Low)
Price
$0.54
Volume
4
Open
$0.54
Previous Close
$0.54
Daily Range
$0.54 - $0.54
52-Week Range
$0.02 - $0.55
CRRTF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Crescita Therapeutics
Industry
Pharmaceuticals
Sector
Health CareEmployees
65
CEO
Serge Verreault, MBA
Website
www.crescitatherapeutics.comHeadquarters
Laval, QC H7V 0A3, CA
CRRTF Financials
Key Financial Metrics (TTM)
Gross Margin
54%
Operating Margin
-5%
Net Income Margin
-0%
Return on Equity
-33%
Return on Capital
-7%
Return on Assets
-0%
Earnings Yield
-0.39%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$10.05M
Shares Outstanding
18.61M
Volume
4
Short Interest
0.00%
Avg. Volume
1.32K
Financials (TTM)
Gross Profit
$10.36M
Operating Income
$1.02M
EBITDA
$478.61K
Operating Cash Flow
$1.07M
Capital Expenditure
$332.73K
Free Cash Flow
$739.40K
Cash & ST Invst.
$8.57M
Total Debt
$333.73K
Crescita Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$5.95M
-13.8%
Gross Profit
$3.03M
+1.3%
Gross Margin
50.98%
N/A
Market Cap
$10.05M
N/A
Market Cap/Employee
$141.57K
N/A
Employees
71
N/A
Net Income
$710.42K
-338.5%
EBITDA
$29.98K
-85.3%
Quarterly Fundamentals
Net Cash
$8.24M
-2.4%
Accounts Receivable
$2.11M
+33.4%
Inventory
$4.72M
+16.5%
Long Term Debt
$0.00
-100.0%
Short Term Debt
$333.73K
-28.8%
Return on Assets
-0.45%
N/A
Return on Invested Capital
-6.55%
N/A
Free Cash Flow
$1.14M
+11.3%
Operating Cash Flow
$415.66K
-69.8%